Joseph Ciaffoni, President and CEO at COLLEGIUM PHARMACEUTICAL, INC (COLL), sold 124,088 shares at $21.58 ($2.7M) on 2023-06-02, disclosed to the SEC on 2023-06-02.
Scheduled sale ($2.7M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.09 | 31,272 | $691K | 25.5% |
| 2 | $22.09 | 31,272 | $691K | 25.5% |
| 3 | $21.58 | 30,272 | $653K | 24.1% |
| 4 | $21.58 | 30,272 | $653K | 24.1% |
| 5 | $22.25 | 1,000 | $22K | 0.8% |
| Total | $21.84 avg | 124,088 |
| $2.7M |
| 100% |
| Filing → |
| COLL | SELL | 2023-06-01 | $2.7M | — | Filing → |
| COLL | SELL | 2023-02-14 | $302K | — | Filing → |
| COLL | SELL | 2022-12-27 | $58K | — | Filing → |